A phase Ib study Combining the mTOR inhibitor everolimus (RAD001) with low-dose cytarabine In untreated elderly AML [Abstract]

Wei, A. H., Sadawarte, S., Catalano, J., Hills, Robert Kerrin ORCID: https://orcid.org/0000-0003-0166-0062, Avery, S., Patil, S. S., Burnett, Alan Kenneth and Spencer, A. 2010. A phase Ib study Combining the mTOR inhibitor everolimus (RAD001) with low-dose cytarabine In untreated elderly AML [Abstract]. Blood 116 (21) , pp. 1351-1352.

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Additional Information:	Abstracts of the Annual Society of Hematology(ASH) Meeting 2010
Publisher:	American Society of Hematology
ISSN:	0006-4971
Last Modified:	24 Oct 2022 11:57
URI:	https://orca.cardiff.ac.uk/id/eprint/49830

Citation Data

Actions (repository staff only)

Edit Item